US FDA Grants Expanded Approval of ELEVIDYS Gene Therapy for DMD Patients Ages 4 and Above

Get Involved

Together with supporters like you, we can make innovative science and care possible for families.

MDA Access Survey

In Market: March - May 2021

MDA Access Survey

MDA launched a survey in 2021 to the neuromuscular community. The MDA Access Survey was developed to better understand some of the common barriers the neuromuscular disease community faces, such as access to equipment, therapies, education, employment, and financial independence. With over 2,800 responses, this survey provided valuable insight into the access barriers the neuromuscular community faces.

View Survey Key Findings